Does INFLIXIMAB Cause Skin lesion? 474 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 474 reports of Skin lesion have been filed in association with INFLIXIMAB (Renflexis). This represents 0.3% of all adverse event reports for INFLIXIMAB.
474
Reports of Skin lesion with INFLIXIMAB
0.3%
of all INFLIXIMAB reports
5
Deaths
106
Hospitalizations
How Dangerous Is Skin lesion From INFLIXIMAB?
Of the 474 reports, 5 (1.1%) resulted in death, 106 (22.4%) required hospitalization, and 2 (0.4%) were considered life-threatening.
Is Skin lesion Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for INFLIXIMAB. However, 474 reports have been filed with the FAERS database.
What Other Side Effects Does INFLIXIMAB Cause?
Off label use (34,801)
Drug ineffective (33,738)
Condition aggravated (16,616)
Rheumatoid arthritis (16,251)
Pain (15,061)
Fatigue (13,473)
Arthralgia (13,441)
Infusion related reaction (12,946)
Product use issue (12,752)
Drug intolerance (11,173)
What Other Drugs Cause Skin lesion?
SECUKINUMAB (1,909)
ADALIMUMAB (1,507)
METHOTREXATE (1,237)
DUPILUMAB (685)
ETANERCEPT (647)
PREDNISONE (617)
TOFACITINIB (478)
CYCLOSPORINE (380)
LENALIDOMIDE (369)
TACROLIMUS (366)
Which INFLIXIMAB Alternatives Have Lower Skin lesion Risk?
INFLIXIMAB vs INFLIXIMAB-ABDA
INFLIXIMAB vs INFLIXIMAB-AXXQ
INFLIXIMAB vs INFLIXIMAB-DYYB
INFLIXIMAB vs INFLIXIMAB-QBTX
INFLIXIMAB vs INFLIXIMAB, RECOMBINANT